Evidence map›Paper›PMID 42197758›Full record

ArticleSensors (Basel, Switzerland)2026

Trans-D3: A Novel Hybrid Transformer-Based Actor-Critic Approach for Remaining Useful Life Prediction.

Jorge Paredes, Danilo Chavez, Ramiro Isa-Jara, Diego Vargas

Abstract read
In one paragraph

Article in Sensors (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jorge ParedesDepartamento de Automatización y Control Industrial, Facultad de Ingeniería Eléctrica y Electrónica, Escuela Politécnica Nacional, Quito 170525, Ecuador.ORCID 0009-0002-2256-3018
Danilo ChavezDepartamento de Automatización y Control Industrial, Facultad de Ingeniería Eléctrica y Electrónica, Escuela Politécnica Nacional, Quito 170525, Ecuador.ORCID 0000-0002-7529-9006
Ramiro Isa-JaraFacultad de Informática y Electrónica, Escuela Superior Politécnica de Chimborazo, Avenida Pedro Vicente Maldonado s/n & Avenida 11 de Noviembre, Riobamba 060104, Ecuador.ORCID 0000-0001-5624-5822
Diego VargasDepartamento de Automatización y Control Industrial, Facultad de Ingeniería Eléctrica y Electrónica, Escuela Politécnica Nacional, Quito 170525, Ecuador.ORCID 0009-0009-9098-9767

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The present article introduces TRANS-D3, an innovative hybrid method that combines the Twin Delayed Deep Deterministic Policy Gradient (TD3) reinforcement learning algorithm with the Transformer architecture for predicting the remaining useful life (RUL). The model utilizes an optimized reward function based on the Linear Quadratic Regulator (LQR) to approach error correction as a dynamic control problem. On the CMAPSS dataset, TRANS-D3 demonstrates a marked advantage, achieving RMSE reductions of 84-90% in baseline situations (FD001) and 23-45% in highly variable contexts (FD003/FD004). Statistical validation demonstrates high reliability, with a coefficient of determination R2 of more than 0.93 in each of the subsets; the maximum is 0.9984 in FD001. The 95% confidence intervals for the mean error, ranging from [0.709 to 1.244] in FD001 and from [-1.324 to 1.748] in FD004, also confirm that the framework is a statistically unbiased estimator. In terms of Score, the model reduces penalties by between 80% and 95% compared to advanced architectures such as DAST or STAR, ensuring very stable predictions. These findings present a novel robust optimization paradigm, which is essential for ensuring the safety and reliability of complex industrial systems in the context of Industry 4.0.

Indexed as

predictive maintenancereinforcement learningremaining useful lifesupervised learningTD3transformer

Identifiers

PMID42197758
PMCPMC13210881

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.